Back Menu
Human Stem Cells Institute

Human Stem Cells Institute PJSC (HSCI, MOEX: ISKJ) is a Russian public biotech company founded in 2003.

Today, HSCI is a strategic investor with diversified assets in high-growth markets related to the development and introduction of innovative drugs, medical devices, genetic testing & genomic analysis, advanced medical and healthcare services.

HSCI invests in various areas and manages assets at different stages of development (startups, early growth companies, mature companies with positive cash flows and stable margins).

As of now, HSCI is the parent holding company which owns over 10 subsidiaries, including one MOEX issuer (IMCB, ticker: GEMA) and five Skolkovo residents.

The HSCI Group aims to improve quality of life and increase life expectancy by pushing forward personalized, predictive and preventive medicine, as well as integrating recent advances in medical genetics, bioinformatics, gene therapy, cell technologies & tissue engineering, biobanking and biopharmaceutics into clinical practice and healthcare.